Hospira Logo (Erythrocin 01)
Erythrocin Lactobionate
Product Images NDC 0409-6476
11 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Erythrocin Lactobionate (NDC 0409-6476). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Erythrocin Lactobionate Structural Formula (Erythrocin 02)
Chemical structure diagram of the active ingredient in Erythrocin Lactobionate by Hospira, Inc. It depicts the molecular bonding and arrangement of atoms including multiple rings and functional groups characteristic of erythromycin lactobionate.*
Figure 1 (Erythrocin 03)
An instructional illustration showing a hand pressing down and turning the cap on a child-resistant or safety closure. The image highlights the downward pressing action with an arrow, demonstrating how to open the container.*
Figure 2 (Erythrocin 04)
An instructional illustration showing a medical vial with a flip-top cap being removed by lifting the tab upwards. The vial represents a container typically used for injectable drugs, demonstrating how to open it prior to use.*
Figure 3 (Erythrocin 05)
An instructional line drawing showing a hand opening the cap on a bottle with a connected flexible tube, which likely represents a step in preparing or administering Erythrocin Lactobionate intravenous solution. The image focuses on the bottle neck and cap removal procedure.*
Figure 4 (Erythrocin 06)
An instructional line drawing showing hands opening a flexible plastic medical fluid container by removing the cap from the port at the top. The illustration depicts the steps for accessing or preparing the container for administration.*
Figure 5 (Erythrocin 07)
An instructional line drawing showing a hand holding a vial or container with a needle or tube inserted, demonstrating a step in the preparation or administration process of a medication. No text or labeling is visible in the image.*
Figure 6 (Erythrocin 08)
An instructional line drawing showing a hand holding a vial that is being connected to an IV bag. The IV bag is depicted partially filled with fluid, with tubing extending from the bottom. The image illustrates the process of inserting the vial into the IV set for medication preparation or administration.*
Hospira Logo (Erythrocin 09)
Principal Display Panel (500 mg Vial Label)
Erythrocin Lactobionate - IV, erythromycin lactobionate for injection USP, 500 mg per vial, sterile powder in a single-dose ADD-Vantage vial. Label indicates preservative-free, for intravenous use only, distributed by Hospira, Inc. Instructions for administration after reconstitution are included, with specific time limits for D5W and 0.9% NaCl diluents. Packaging includes NDC 0409-6476-54 and lot/expiration placeholders.*
Principal Display Panel (500 mg Vial Tray Label)
Packaging label for Erythrocin Lactobionate for Injection, USP, 500 mg per vial. The label indicates it is sterile powder for injection, preservative-free, and intended for intravenous use only. It is a single-dose vial in a package of 10, distributed by Hospira, Inc. The label includes notes on reconstitution and storage conditions, and displays NDCs 0409-6476-44 and 0409-6476-54.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
